<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Cancer Discov</journal-id>
        <journal-id journal-id-type="iso-abbrev">Cancer Discov</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Cancer discovery</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">2159-8274</issn>
        <issn pub-type="epub">2159-8290</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC11149479</article-id>
        <article-id pub-id-type="pmcid-ver">PMC11149479.319</article-id>
        <article-id pub-id-type="pmcaid">11149479</article-id>
        <article-id pub-id-type="pmcaiid">11149479</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1930108</article-id>
        <article-id pub-id-type="pmid">37651310</article-id>
        <article-id pub-id-type="doi">10.1158/2159-8290.CD-23-0546</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1930108</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1930108</article-id>
        <article-version article-version-type="pmc-version">319</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Molecular characterization of endometrial carcinomas in Black and White patients reveals disparate drivers with therapeutic implications</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Weigelt</surname>
              <given-names initials="B">Britta</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Marra</surname>
              <given-names initials="A">Antonio</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Selenica</surname>
              <given-names initials="P">Pier</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rios-Doria</surname>
              <given-names initials="E">Eric</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Momeni-Boroujeni</surname>
              <given-names initials="A">Amir</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Arora</surname>
              <given-names initials="K">Kanika</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Nemirovsky</surname>
              <given-names initials="D">David</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Iasonos</surname>
              <given-names initials="A">Alexia</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chakravarty</surname>
              <given-names initials="D">Debyani</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Abu-Rustum</surname>
              <given-names initials="NR">Nadeem R.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Da Cruz Paula</surname>
              <given-names initials="A">Arnaud</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dessources</surname>
              <given-names initials="K">Kimberly</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ellenson</surname>
              <given-names initials="LH">Lora H.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names initials="YL">Ying L.</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Aghajanian</surname>
              <given-names initials="C">Carol</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
            <xref rid="A7" ref-type="aff">7</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Brown</surname>
              <given-names initials="CL">Carol L.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A8" ref-type="aff">8</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A2"><label>2</label>Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A3"><label>3</label>Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer, Center, New York, NY</aff>
        <aff id="A4"><label>4</label>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A5"><label>5</label>Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY</aff>
        <aff id="A6"><label>6</label>Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A7"><label>7</label>Department of Medicine, Weill Cornell Medical College, New York, NY</aff>
        <aff id="A8"><label>8</label>Office of Health Equity, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <author-notes>
          <fn fn-type="equal" id="FN1">
            <label>*</label>
            <p id="P1">Equal contribution</p>
          </fn>
          <fn fn-type="present-address" id="FN2">
            <p id="P2">Current address for A. Marra: European Institute of Oncology IRCCS, Milan, Italy, for E. Rios-Doria: UW Medical Center, Seattle, WA, for A. Da Cruz Paula: Institute for Research and Innovation in Health, University of Porto, Porto, Portugal, and for K. Dessources: UNC Health, Chapel Hill, NC.</p>
          </fn>
          <fn fn-type="con" id="FN3">
            <p id="P3">Authors’ Contributions</p>
            <p id="P4">B. Weigelt: Conceptualization, data curation, investigation, visualization, supervision, writing - original draft, writing - review and editing. A. Marra: Data curation, investigation, formal analysis, software, methodology, visualization, writing - original draft, writing - review and editing. P. Selenica: Formal analysis, data curation, software, investigation, writing - review and editing. E. Rios-Doria: Data curation, writing - review and editing. A. Momeni-Boroujeni: Pathology review, writing - review and editing. M.F. Berger: Supervision, data curation, writing - review and editing. K. Arora: Formal analysis, writing - review and editing. D. Nemirovsky: Formal analysis, statistical analysis, writing - review and editing. A. Iasonos: Formal analysis, statistical analysis, writing - review and editing. D Chakravarty: Methodology, writing - review and editing. N.R. Abu-Rustum: Resources, writing - review and editing. A. Da Cruz Paula: Data curation, visualization, writing - review and editing. K. Dessources: Conceptualization, writing - review and editing. L.H. Ellenson: Conceptualization, investigation, pathology review, writing - review and editing. Y.L. Liu: Conceptualization, methodology, writing - original draft, writing - review and editing. C Aghajanian: Conceptualization, resources, writing - review and editing. C.L. Brown: Conceptualization, supervision, funding acquisition, project administration, writing - review and editing.</p>
          </fn>
          <corresp id="CR1"><bold>Corresponding authors: Carol L. Brown</bold>, Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. <email>Brown4@mskcc.org</email>. <bold>Britta Weigelt</bold>, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. <email>weigeltb@mskcc.org</email>.</corresp>
          <fn fn-type="COI-statement" id="FN4">
            <p id="P37"><bold>Conflict of interest statement:</bold> M.F. Berger reports consulting fees for AstraZeneca and Eli Lilly, outside the scope of the current work. B. Weigelt reports research funding from Repare Therapeutics, outside the current study. Y.L. Liu reports research funding from AstraZeneca, GSK, and Repare Therapeutics. C. Aghajanian has received research grants from Abbvie, Clovis, Genentech, and Astra Zeneca and served on advisory boards for Abbvie, AstraZeneca/Merck, Eisai/Merck, Mersana Therapeutics, Repare Therapeutics, and Roche/ Genentech, outside the current study. N. Abu-Rustum reports grant funding from GRAIL paid to the institution. All other authors have no potential conflicts of interest to disclose.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>01</day>
          <month>11</month>
          <year>2023</year>
        </pub-date>
        <volume>13</volume>
        <issue>11</issue>
        <issue-id pub-id-type="pmc-issue-id">464085</issue-id>
        <fpage>2356</fpage>
        <lpage>2369</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>23</day>
              <month>05</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>04</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>04</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-06 09:25:31.473">
              <day>06</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1930108.pdf"/>
        <abstract id="ABS1">
          <p id="P5">Although the incidence of endometrial carcinoma (EC) is similar in Black and White women, racial disparities are stark with the highest mortality rates observed among Black patients. Here, analysis of 1,882 prospectively sequenced ECs using a clinical FDA-authorized tumor-normal panel revealed a significantly higher prevalence of high-risk histologic and molecular EC subtypes in self-identified Black (n=259) compared to White (n=1,623) patients. Clinically actionable alterations, including high tumor mutational burden/ microsatellite-instability, which confer benefit from immunotherapy, were less frequent in ECs from Black than from White patients. Ultramutated <italic toggle="yes">POLE</italic> molecular subtype ECs associated with favorable outcomes were rare in Black patients. Results were confirmed by genetic ancestry analysis. <italic toggle="yes">CCNE1</italic> gene amplification, which is associated with aggressive clinical behavior, was more prevalent in carcinosarcomas occurring in Black than in White patients. ECs from Black and White patients display important differences in their histologic types, molecular subtypes, driver genetic alterations and therapeutic targets.</p>
        </abstract>
        <kwd-group>
          <kwd>Clinical sequencing</kwd>
          <kwd>endometrial carcinoma</kwd>
          <kwd>ancestry</kwd>
          <kwd>molecular subtypes</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
